Well, as we have been predicting here for weeks, Acomplia was not withdrawn from the European market when the European Medicines Agency’s Committee on Medicinal Products for Human Use reported earlier today. Advice to doctors has changed very slightly relating to patients being treated for depression. We have never prescribed Acomplia for any patient who was also being treated for depressions as we considered the risks of psychiatric side effects to be too great. So as far as we are concerned, nothing has changed. As always, if any of our patients develop depression while on Acomplia then they should contact us straight away and cease treatment immediately.